Literature DB >> 9679566

Glutathione S-transferase polymorphisms: influence on susceptibility to cancer.

R C Strange1, J T Lear, A A Fryer.   

Abstract

The glutathione S-transferase supergene family includes several loci that demonstrate well characterised polymorphisms. The apparently critical role of these enzymes in cellular protection from the cytotoxic and mutagenic effects of electrophiles suggest that alleles associated with impaired detoxification will confer an increased susceptibility to a wide range of diseases. This hypothesis has been examined in case control studies and while data in some diseases such as lung cancer are conflicting, an increasing body of evidence suggests the importance of several glutathione S-transferase polymorphisms. In particular, GST genotypes have been associated with an increased susceptibility or worse outcome in diseases associated with oxidative stress. For example, both GSTM1 and GSTT1 genotypes are associated with susceptibility and outcome in cutaneous basal cell carcinoma. It still remains unclear however, why particular glutathione S-transferase loci are associated with altered risk in some diseases but not others. Further, the true in vivo substrates of these enzymes is unknown, consequently their mechanism of action remains unclear.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679566     DOI: 10.1016/s0009-2797(97)00172-5

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  15 in total

1.  Association of GSTs polymorphisms with risk of gestational diabetes mellitus.

Authors:  Yan Li; Shaoru Li; Qianqian Zhai; Jie Hai; Di Wang; Meng Cao; Qinggui Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.

Authors:  Zeyuan Lei; Ting Liu; Xiang Li; Xiaoxia Xu; Dongli Fan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Glutathione-S-Transferase M1 null genotype in autoimmune hepatitis.

Authors:  N K Fukagawa; P Liang; M Li; T Ashikaga; K R Reddy; E L Krawitt
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

4.  Significant associations between GSTM1/GSTT1 polymorphisms and nasopharyngeal cancer risk.

Authors:  Yumei Wei; Tao Zhou; Haiqun Lin; Mingping Sun; Dongqing Wang; Hongsheng Li; Baosheng Li
Journal:  Tumour Biol       Date:  2012-12-30

5.  Quantitative assessment of the association between glutathione S-transferase M1 polymorphism and the risk of developing nasopharyngeal cancer.

Authors:  Yan Zhao; Yubao Wang; Xiaomei Wu; Jun Wang; Lijuan Zhang; Yuchi Jia; Wei Qi
Journal:  Oncol Lett       Date:  2015-10-30       Impact factor: 2.967

6.  Correlation of GSTP1 gene variants of male Iraqi waterpipe (Hookah) tobacco smokers and the risk of lung cancer.

Authors:  Bassam K Kudhair; Noralhuda N Alabid; Asghar Taheri-Kafrani; Inam J Lafta
Journal:  Mol Biol Rep       Date:  2020-03-03       Impact factor: 2.316

7.  Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas.

Authors:  Rona Ezer; Michelle Alonso; Elaine Pereira; Mimi Kim; Jeffrey C Allen; Douglas C Miller; Elizabeth W Newcomb
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

8.  Glutathione S-transferase M1, T1, and P1 gene polymorphisms and carotid atherosclerosis in Korean patients with rheumatoid arthritis.

Authors:  Jae-Hong Park; Ahmed El-Sohemy; Marilyn C Cornelis; Hyun-Ah Kim; Shin-Yoon Kim; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

9.  Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients.

Authors:  Jianfeng Bai; Naohiro Sata; Hideo Nagai
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma.

Authors:  Sayaka Kondo; Erich M Sturgis; Fanglin Li; Qingyi Wei; Guojun Li
Journal:  Int J Clin Exp Med       Date:  2009-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.